Loading clinical trials...

The Nanowear Wearable Covid-19 Observational and Analysis Trend | Clinical Trials | Clareo Health

UNKNOWN

The Nanowear Wearable Covid-19 Observational and Analysis Trend

NCT04717024•Nanowear Inc.

Summary

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subject has provided informed consent
•Male or female over the age of 18 years
•The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion Criteria

•Subject is unwilling or unable to wear the vest during hospitalization.
•Subjects who are pregnant.
•Subject is intubated or admitted to ICU
•Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)

Locations (2)

Hackensack University Medical Center

Hackensack, New Jersey, United States

Maimonides Medical Center

Brooklyn, New York, United States

Key Dates

Start Date

September 15, 2020

Primary Completion Date

December 31, 2023

Completion Date

December 31, 2023

Last Updated

November 8, 2023

Enrollment

100

ESTIMATED participants

Conditions

Covid19

Interventions

Observational Study - no intervention

DEVICE

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716

Covid19Surgery

View study

RECRUITINGPHASE3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796

Critical IllnessVitamin D Deficiency+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Nanowear Wearable Covid-19 Observational and Analysis Trend

Inclusion Criteria

Exclusion Criteria

The Effect of the Covid-19 Pandemic Among Operated Patients

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Covid-19 and Influenza Oral Vaccine Study

Conversations You Want About Corona Virus Disease (COVID-19)

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy